KLOR-CON M (Page 3 of 3)
HOW SUPPLIED
Klor-Con® M10 Extended-release Tablets, contains 750 mg of potassium chloride (equivalent to 10 mEq of potassium) are white, oblong tablets and imprinted “KC M10”. They are supplied as follows:
Bottles of 90 tablets | NDC 0245-5317-90 |
Bottles of 100 tablets | NDC 0245-5317-11 |
Bottles of 1,000 tablets | NDC 0245-5317-10 |
Unit-dose cartons of 100 tablets | NDC 0245-5317-01 |
Klor-Con® M15 Extended-release Tablets, contains 1,125 mg of potassium chloride (equivalent to 15 mEq of potassium) are white, oblong tablets and imprinted “M 15” and scored for flexibility of dosing. They are supplied as follows:
Bottles of 100 tablets | NDC 0245-5318-11 |
Unit-dose cartons of 100 tablets | NDC 0245-5318-01 |
Klor-Con® M20 Extended-release Tablets, contains 1,500 mg of potassium chloride (equivalent to 20 mEq of potassium) are white, oblong tablets and imprinted “KC M20” and scored for flexibility of dosing. They are supplied as follows:
Bottles of 90 tablets | NDC 0245-5319-90 |
Bottles of 100 tablets | NDC 0245-5319-11 |
Bottles of 500 tablets | NDC 0245-5319-15 |
Bottles of 1,000 tablets | NDC 0245-5319-10 |
Unit-dose cartons of 100 tablets | NDC 0245-5319-01 |
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
Keep tightly closed.
Manufactured by
UPSHER-SMITH LABORATORIES, LLC
Maple Grove, MN 55369
Klor-Con and Micro-Dispersible Technology are registered trademarks of Upsher-Smith Laboratories, LLC.
This product may be covered by one or more U.S. patent(s). See www.uslpatents.com.
Certain manufacturing operations have been performed by other firms.
Revised 0319
PRINCIPAL DISPLAY PANEL — 10 mEq K Tablet Bottle Label
NDC 0245-5317-11
Klor-Con® M10
Potassium Chloride
Extended-Release
Tablets, USP
MICRO-DISPERSIBLE TECHNOLOGY®
10 mEq K
100 Tablets
Rx only
UPSHER-SMITH
PRINCIPAL DISPLAY PANEL — 15 mEq K Tablet Bottle Label
NDC 0245-5318-11
Klor-Con® M15
Potassium Chloride
Extended-Release Tablets, USP
MICRO-DISPERSIBLE TECHNOLOGY®
15 mEq K
100 Tablets
Rx only
UPSHER-SMITH
PRINCIPAL DISPLAY PANEL — 20 mEq K Tablet Bottle Label
NDC 0245-5319-11
Klor-Con® M20
Potassium Chloride
Extended-Release Tablets, USP
MICRO-DISPERSIBLE TECHNOLOGY®
20 mEq K
100 Tablets
Rx only
UPSHER-SMITH
KLOR-CON M potassium chloride tablet, extended release | |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
|
KLOR-CON M potassium chloride tablet, extended release | |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
KLOR-CON M potassium chloride tablet, extended release | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
|
Labeler — Upsher-Smith Laboratories, LLC (079111820) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Upsher-Smith Laboratories, LLC | 079111820 | MANUFACTURE (0245-5317), MANUFACTURE (0245-5318), MANUFACTURE (0245-5319), PACK (0245-5317), PACK (0245-5318), PACK (0245-5319), LABEL (0245-5317), LABEL (0245-5318), LABEL (0245-5319) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Upsher-Smith Laboratories, LLC | 047251004 | ANALYSIS (0245-5317), ANALYSIS (0245-5318), ANALYSIS (0245-5319) |
Revised: 12/2020 Upsher-Smith Laboratories, LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.